AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
AstraZeneca(AZN) stock is priced at $174.30, giving the company a market capitalization of 270.54B. It carries a P/E multiple of 24.66 and pays a dividend yield of 1.82%.
On 2026-11-21, AstraZeneca(AZN) stock traded between a low of $174.06 and a high of $177.47. Shares are currently priced at $174.30, which is +0.1% above the low and -1.8% below the high.
AstraZeneca(AZN) shares are trading with a volume of 2M, against a daily average of 2.07M.
During the past year, AstraZeneca(AZN) stock moved between $153.41 at its lowest and $212.71 at its peak.
During the past year, AstraZeneca(AZN) stock moved between $153.41 at its lowest and $212.71 at its peak.
AZN News
Tempus AI Inc. (NYSE:TEM) and AstraZeneca Plc. (NASDAQ:AZN) on Monday amended their master services agreement, extending the partnership through Dec. 31, 2031,...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s GRACE-DE study, officially titled “Prospective, Obs...
AstraZeneca (AZN) announced on Thursday that the Food and Drug Administration accepted and issued a priority review for its marketing application for its gastri...
Analyst ratings
82%
of 11 ratingsMore AZN News
Tempus AI, Inc. Class A, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Yi Chen from H.C. Wainwright reiterated a Buy rati...
AstraZeneca’s (AZN) Biologics License Application, BLA, for sonesitatug vedotin, Sone-Ve, has been accepted and granted Priority Review in the US for the 2nd an...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca plc is evaluating Lokelma in Indian adults with mild...
Tempus AI, Inc. Class A ( (TEM) ) just unveiled an announcement. On November 16, 2026, Tempus AI and AstraZeneca entered a fifth amendment to their master serv...
Chicago, IL – November 18, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the...
LBT Innovations Limited ( (AU:CC5) ) has shared an announcement. Clever Culture Systems supplies APAS automated culture-plate reading technology for pharmaceut...
Regulators in the U.S. and European Union handed AstraZeneca Plc (NYSE:AZN) major regulatory wins across rare neuromuscular disease and oncology. The agencies...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.